On July 11, 2012, Merus Labs International Inc. acquired Emselex®/Enablex®. Stewart Muglich and Victor Dudas of our Corporate Finance & Securities Group handled the debt facility between Merus and PDL BioPharma Inc., a company that supports the healthcare industry with creative financing solutions, assisted by Amaan Gangji and Kevin MacDonald. The transaction involved counsel from Toronto, New York, Switzerland, the Netherlands and Luxembourg.
Related Content
Protecting Your Technology
When starting a new company, it is critically important to go through the trouble of reviewing what information or technology the company has and assessing ... Continued
Do The New Registration Thresholds in the U.S. Really Help? New Rule 12g-1
The Jumpstart Our Business Startups Act (known as the JOBS Act), which became law in 2012, was intended to encourage investment in small businesses by ... Continued
Bill 25: Proposed Changes to REDMA
Bill 25 – 2018: Real Estate Development Marketing Amendment Act is subject to change. We will update these changes as they develop. For the latest ... Continued